| Overview |
| bs-17671R |
| SPINK4 Polyclonal Antibody |
| IHC-P, IHC-F, IF(ICC), IF |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human SPINK4 |
| 27-86/86 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. |
| Store at -20¡C for 12 months. |
| Target |
| 27290 |
| O60575 |
| Gastrointestinal peptide; ISK4_HUMAN; PEC 60; PEC60; Peptide PEC-60 homolog; Serine peptidase inhibitor Kazal type 4; Serine protease inhibitor Kazal-type 4; SPINK4. |
| SPINK4 is an 86 amino acid secreted protein containing one kazal-like domain, which has been suggested to play a role in central nervous system disorders associated with dopamine dysregulation. Expressed in the gastrointestinal tract, central nervous system, bone marrow and peripheral blood, SPINK4 is moderately expressed in spleen and is encoded by a gene mapping to human chromosome 9p13.3. Human chromosome 9 houses over 900 genes and comprises nearly 4% of the human genome. Hereditary hemorrhagic telangiectasia, which is characterized by harmful vascular defects, and Familial dysautonomia, are both associated with chromosome 9. |
| Application Dilution |
| IHC-P |
1:200-400 |
| IHC-F |
1:100-500 |
| IF(ICC) |
1:50-200 |
| IF |
|
Powered by Bioz